Phase II trial of spirogermanium in central nervous system tumors: a Southwest Oncology Group Study

Cancer Treat Rep. 1987 Jan;71(1):99-100.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Cerebral Hemorrhage / chemically induced
  • Chemical and Drug Induced Liver Injury
  • Drug Evaluation
  • Female
  • Germanium / adverse effects
  • Germanium / therapeutic use*
  • Glioma / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Nervous System Neoplasms / drug therapy*
  • Organometallic Compounds*
  • Spiro Compounds / adverse effects
  • Spiro Compounds / therapeutic use*

Substances

  • Organometallic Compounds
  • Spiro Compounds
  • Germanium
  • spirogermanium